Qiang Zhou

机构：Jiangsu University, University of Electronic Science and Technology of China, Hangzhou Normal University, Hunan Normal University, Shanghai University of Traditional Chinese Medicine, Sichuan Cancer Hospital, Jintan People's Hospital, Yueyang Second People's Hospital, Yueyang Hospital · ORCID：0000-0003-4340-9781

发表论文 127 篇 · 总被引 3592 次 · h-index 32

代表论文

• Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma (2023 · Journal for ImmunoTherapy of Cancer · 被引 40)
• Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment (2023 · Cellular Reprogramming · 被引 18)
• Artificial intelligence in tumor drug resistance: Mechanisms and treatment prospects (2025 · Intelligent Oncology · 被引 15)
• CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxia (2023 · Cell Death and Disease · 被引 11)
• FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinoma (2024 · The Oncologist · 被引 10)
• miR ‐199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1 (2023 · The Kaohsiung Journal of Medical Sciences · 被引 8)